In experimental models of colitis, selenium-containing amino acids, including selenocysteine and selenocystine, have demonstrated significant protective effects by reducing ROS production, increasing antioxidant enzyme activity, and suppressing the expression of pro-inflammatory cytokines, particularly TNF-α and IL-6 [31]. The gene discussed is IL6; the disease is colitis.